These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36325327)

  • 1. Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():1047151. PubMed ID: 36325327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
    Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
    Front Immunol; 2022; 13():944740. PubMed ID: 35812444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
    Huang S; Dong C; Li D; Xu Y; Wu J
    Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma.
    Huang S; Li D; Zhuang L; Sun L; Wu J
    Front Mol Biosci; 2021; 8():690151. PubMed ID: 34307456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer.
    Liu S; Tang W; Cao J; Shang M; Hengchang S; Gong J; Hu B
    Front Genet; 2024; 15():1357409. PubMed ID: 38343696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis.
    Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L
    Front Cell Dev Biol; 2022; 10():1009752. PubMed ID: 36225317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis.
    Zhang YZ; Zeb A; Cheng LF
    Front Immunol; 2023; 14():1168774. PubMed ID: 36926336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():979968. PubMed ID: 36072794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
    Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma.
    Fu LL; Yan M; Ma MX; Luo Y; Shao M; Gosau M; Friedrich RE; Vollkommer T; Feng HC; Smeets R
    Front Immunol; 2022; 13():1099835. PubMed ID: 36505490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
    Guo Y; Cen K; Chen Q; Dai Y; Mai Y; Hong K
    Front Immunol; 2023; 14():1229541. PubMed ID: 37342331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis.
    Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L
    Front Cell Dev Biol; 2024; 12():1392532. PubMed ID: 38645409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.
    Ke Q; Xin F; Fang H; Zeng Y; Wang L; Liu J
    Front Immunol; 2022; 13():952446. PubMed ID: 35747141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expression of Actin-Related Protein 2/3 Complex Subunit 5 (ARPC5) Expression in Multiple Myeloma and its Prognostic Significance.
    Xiong T; Luo Z
    Med Sci Monit; 2018 Sep; 24():6340-6348. PubMed ID: 30201948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker.
    Liu K; Cui L; Li C; Tang C; Niu Y; Hao J; Bu Y; Chen B
    Front Genet; 2022; 13():922472. PubMed ID: 35991576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3.
    Wu Y; Zhang B; Nong J; Alarcon Rodriguez R; Guo W; Liu Y; Zhao S; Wei R
    Front Genet; 2023; 14():1204421. PubMed ID: 37287535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer.
    Yang A; Zhou Y; Kong Y; Wei X; Ye F; Zhang L; Zhong X; Li M; Lu S; An X; Xiao W
    Front Immunol; 2024; 15():1372991. PubMed ID: 38357539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Hu X; Bao M; Huang J; Zhou L; Zheng S
    Front Oncol; 2020; 10():617539. PubMed ID: 33330112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Development of a phagocytosis- dependent gene signature to predict prognosis and response to checkpoint inhibition in clear-cell renal cell carcinoma.
    Li K; Li Y; Lyu Y; Tan L; Zheng X; Jiang H; Wen H; Feng C
    Front Immunol; 2023; 14():1140764. PubMed ID: 36742313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.